Clear Street LLC Bluebird Bio, Inc. Transaction History
Clear Street LLC
- $10 Billion
- Q4 2024
A detailed history of Clear Street LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Clear Street LLC holds 6,000 shares of BLUE stock, worth $24,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,000Holding current value
$24,000% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BLUE
# of Institutions
18Shares Held
20.2MCall Options Held
0Put Options Held
2K-
Black Rock Inc. New York, NY15.4MShares$61.8 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$18.7 Million0.02% of portfolio
-
Colony Group LLC Boston, MA41.9KShares$167,7680.0% of portfolio
-
Connacht Asset Management LP New York, NY31.6KShares$126,5360.59% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL28.7KShares$114,8400.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $308M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...